Table 4.

Percentage of subjects experiencing an adverse event deemed possibly, probably, or definitely related to treatment (based on ATD population)

Event	C31G (N=836)	Conceptrol (N=560)	p
Women who experienced any AE related to study drug (%)(possible-probable-definite)	35	41	0.023
Bacterial vaginosis	10	11
Fungal vaginitis	10	11
Urinary tract infection	8	10
Genital pruritus	3	6
Menstrual irregularities	5	4
Product discontinuation due to AE	2	2

Events listed are those reported by at least 2% of subjects in each group, and could have occurred at any time during study participation.